News About: Pharm. Industry
Korea Bone Bank to conduct clinical test over bone morphogenetic protein 2
Korea Bone Bank Corp., a local medical devices maker founded in 1997, said it will carry out a clinical trial on bone morphogenetic protein (BMP2), which stimulates bone formation. Products containing the protein are ...
Choong-wae Med’s direct digital radiography obtains US FDA certification
Local medical device maker Choong-wae Medical Corporation, an affiliated company of Choong-wae Holdings, said on July 29 that its homegrown Direct Digital Radiography (DDR) was certified by the US Food and Drug Admini...
Schering-Plough Korea launches awareness campaign on autoimmune diseases
Schering-Plough Korea is spearheading a new educational campaign “Hope Story” to raise awareness about autoimmune diseases, such as rheumatoid arthritis, Crohn's disease and spondylitis, along with 23 university hospi...
Vytorin price to be lowered by 32.8%
MSD Korea said the insurance price of its lipid-lowering agent Vytorin 10 mg (ezetimibe/simvastatin) will be reduced by 32.8% by next January upon its voluntary decision.
A company official said this price cut may ...
More tax exemptions set for R&D spending
Korea seeks to expand tax exemptions for corporate investment in research and development (R&D) as part of efforts to stimulate state-run and private companies’ R&D spending in the era of free trade agreements (FTAs)....
Green Cross reports positive results from phase 3 trials of Peramivir for influenza
Green Cross Corporation announced on July 28 the positive results from two Phase 3 studies of intravenous peramivir in patients with seasonal influenza.
The studies were sponsored by the US based BioCryst's partner...
Pharmaceutical firms urged to improve salespersons morale
Korean drug makers should need to boost the morale of their sales forces amid more cut-throat competition in domestic pharmaceutical market,
Pharmaceutical companies have been blamed for what is called “rebate” pra...
Green Cross obtains exclusive distribution rights for somatostatin injection
Green Cross Corporation said on July 24 it has signed an agreement with he Korean subsidiary of Merck KGaA Germany for the exclusive distribution rights in Korea for Stilamin injection (somatostatin acetate).
Somat...
Chong Kun Dang Bio gets EDQM certification
Chong Kun Dang Bio, an affiliate company of Chong Kun Dang Pharmaceutical Co., said on July 22 it has received a CEP (Certificate of European Pharmacopoeia) from the European Directorate for the Quality of Medicines &...
Wonik to team up with Solta Medical
Wonik Corp., a local medical device company, plans to strengthen its ties with with the US based Solta Medical Inc. as an official business partner in Korea.
Solta Medical is a global leader in the medical aestheti...
